R Fitzpatrick

606 citations
28 papers · 440 indexed · h-index 11
Topics
Biosimilars and Bioanalytical Methods (9 papers)Health Systems, Economic Evaluations, Quality of Life (8 papers)Healthcare cost, quality, practices (6 papers)

In The Last Decade

R Fitzpatrick

27 papers receiving 418 citations

Peers

R Fitzpatrick
Comparison fields: 5 of 90
  • Immunology 189
  • Economics and Econometrics 182
  • Pediatrics, Perinatology and Child Health 108
  • General Health Professions 68
  • Public Health, Environmental and Occupational Health 59
Replace Christine Leopold with:
Christine Leopold United States
Edward C. Li United States
Claudia Habl Austria
Hye-Young Kwon South Korea
Imma Danés Spain
Cristina Aguilera Spain
Agnès Saint-Raymond Netherlands
Andrea Belisari Italy
Anna Bucsics Austria
Stella Stergiopoulos United States
R Fitzpatrick relative to Christine Leopold United States Christine Leopold's profile →
Citations per field
00.5×4.6×
Christine Leopold · 1×
Citations per year

Countries citing papers authored by R Fitzpatrick

Since Specialization
Citations

This map shows the geographic impact of R Fitzpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Fitzpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Fitzpatrick more than expected).

Fields of papers citing papers by R Fitzpatrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Fitzpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Fitzpatrick. The network helps show where R Fitzpatrick may publish in the future.

Co-authorship network of co-authors of R Fitzpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of R Fitzpatrick. A scholar is included among the top collaborators of R Fitzpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Fitzpatrick. R Fitzpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 5
4 34
5 38
6 36
7 5
8 41
9 25
10 41
11 5
12 1
13
THE USE OF PATIENT-REPORTED OUTCOME MEASURES (PROMs) FOR PROPLE WITH THE FOUR MOST COMMON CANCERS IN THE UK – A STRUCTURED REVIEW
1
14
A STRUCTURED REVIEW OF PATIENT-REPORTED OUTCOME MEASURES (PROMs) FOR PROSTATE CANCER
5
15 7
16 40
17 4
18 6
19 3
20
Ibuprofen toxicity. A review of adverse reactions and overdose.
44

About R Fitzpatrick

R Fitzpatrick is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Pharmacology, having authored 28 papers that have together received 440 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Healthcare cost, quality, practices (6 papers). The work is most often cited by research in Immunology (189 citations), Applied Microbiology and Biotechnology (15 citations) and Economics and Econometrics (182 citations). R Fitzpatrick has collaborated with scholars based in United Kingdom, Iraq and Portugal. Frequent co-authors include Stephen Chapman, G N Volans, Ian Jackson, Ian Smith, Mary Minton, Jonathan Underhill, Nenad Miljković, M. I. Drury, P Yudkin and Louise Jones. Their work appears in journals such as BMJ Open, Cancers and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026